Note: Ingredients listed on restricted chemical lists
General Information
Version
26/08/2022
Revision date
2022-08-26
Product name
G15 ERADITAR
1.2.1 Relevant identified uses
Industrial purposes of the substance or
1.2.2. Uses advised against
No special
Icons in SDS
Company Information
company name
Orca Hygiene
e-mail address of the competent person responsible for the Safety Data Sheet
technical@orcahygiene.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304, H315, H319, H335, H373
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Asp. Tox. 1; H304, May be fatal if swallowed and enters airways. Skin Irrit. 2; H315, Causes skin irritation. Eye Irrit. 2; H319, Causes serious eye irritation. STOT SE 3; H335, May cause respiratory irritation. STOT RE 2; H373, May cause damage to organs through prolonged or repeated exposure.
Signal word
Danger
Hazard statements
May be fatal if swallowed and enters airways. (H304) Causes skin irritation. (H315) Causes serious eye irritation. (H319) May cause respiratory irritation. (H335) May cause damage to organs through prolonged or repeated exposure. (H373)
Precautionary statements
General : -
Prevention
Do not breathe vapour/mist. (P260) Wear eye protection/protective gloves. (P280)
Response
Get medical advice/attention if you feel unwell. (P314) IF SWALLOWED: Immediately call a POISON CENTER/doctor. (P301+P310)
Storage
Store in a well-ventilated place. Keep container tightly closed. (P403+P233)
Disposal
Dispose of contents/container to an approved waste disposal plant. (P501)
Hazardous Ingredients
Hydrocarbons, C11-C14, n-alkanes, isoalkanes, cyclics, <2% aromatics m-xylene;xylene;o-xylene;p-xylene
Additional information
EUH066, Repeated exposure may cause skin dryness or cracking.
2.3 Other hazards
Additional warnings : This mixture/product does not contain any substances considered to meet the criteria classifying them as PBT and/or vPvB. This product does not contain any substances considered to be endocrine disruptors in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.
